ERADEC Trademark

Medicines for human purposes for the treatment of cancer, neoplastic diseases, metabolic diseases, neurologic disorder, neurodegenerative diseases, autoimmune diseases, and immunological diseases; Pharmaceutical preparations for the treatment of cancer, neoplastic diseases, metabolic diseases, neurologic disorder, neurodegenerative diseases, autoimmune diseases, and immunological diseases; Chemico-pharmaceutical preparations for the treatment of cancer, neoplastic diseases, metabolic diseases, neurologic disorder, neurodegenerative diseases, autoimmune diseases, and immunological diseases; Drugs for medical purposes, namely, small molecule drugs for targeted protein degradation; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer, neoplastic diseases, metabolic diseases, neurologic disorder, neurodegenerative diseases, autoimmune diseases, and immunological diseases via targeted protein degradation

Technical research in the field of targeted protein degradation; Research and development of new products for others; Chemical analysis; Chemical analysis services; Chemical research; Bacteriological research and development; Biological research; Medical and scientific research, namely, conducting clinical trials for others; Medical research and development of therapeutics; Pharmaceutical development